HLA-DR matching is effective in reducing posttransplant costs in renal allograft recipients on triple therapy. [electronic resource]
Producer: 19930325Description: 210-1 p. digitalISSN:- 0041-1345
- Antilymphocyte Serum -- therapeutic use
- Costs and Cost Analysis
- Cyclosporine -- therapeutic use
- Graft Rejection
- HLA-DR Antigens -- analysis
- Histocompatibility Testing
- Humans
- Immunosuppression Therapy -- methods
- Kidney Transplantation -- economics
- Prednisolone -- therapeutic use
- Retrospective Studies
- Survival Analysis
- Transplantation, Homologous
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.